<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
    <channel>
        <title>PR.com Press Releases: NCSRT, Inc. News</title>
        <description>Latest news releases from PR.com for NCSRT, Inc.</description>
        <link>http://www.pr.com/press-releases</link>
        <lastBuildDate>Mon, 13 Oct 2008 14:35:21 -0500</lastBuildDate>
        <image>
            <url>http://www.pr.com/images/logo_white.jpg</url>
            <title>Press Releases from PR.com</title>
            <link>http://www.pr.com/</link>
            <width>68</width>
            <height>69</height>
            <description>PR.com provides Free Press Release Distribution, &amp; is a unique Directory of Businesses, Products, Services, &amp; Jobs - in all industries.  Find Full Company Profiles.</description>
        </image>
        <copyright>© 2008 PR Worldwide, Inc.</copyright>
        <ttl>60</ttl>
        <item>
            <title>NCSRT Launches DiaSync for Improved Yield, Lower Cost in Harvest, Concentration, and Diafiltration of Biomolecules</title>
            <link>http://www.pr.com/press-release/75257</link>
            <description>At the Antibody Development and Production meeting in San Diego, CA March 12, 2008, NCSRT is launching its DiaSync process for biomolecules from fermentation, cell culture, or extraction.

Utilizing concurrent processing technology and the patented SmartFlow&amp;trade; TFF technology, DiaSync provides manufacturing with:

&amp;bull; Higher yields &amp;ndash; which translates into fewer fermentation or cell culture campaigns and [PR.com - March 12, 2008]</description>
            <author>NCSRT, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/75257</guid>
        </item>
        <item>
            <title>NCSRT Presents SmartFlow™ TFF Performance Advantages Over Centrifugation and Microfiltration for Monoclonal Antibody Recovery, Concentration and Diafiltration</title>
            <link>http://www.pr.com/press-release/71130</link>
            <description>NCSRT is presenting &amp;ldquo;A comparison of product yield using either centrifugation and microfiltration or simultaneous membrane processing with SmartFlow&amp;trade; TFF&amp;rdquo; at the Waterside Conference in Miami, FL. The data, generated by Viventia Biotech of Winnipeg, Manitoba, Canada, demonstrates monoclonal antibody F (ab) fragment yield improvements of 345% when compared to centrifugation, microfiltration, and [PR.com - February 08, 2008]</description>
            <author>NCSRT, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/71130</guid>
        </item>
        <item>
            <title>NCSRT Introduces WORKS™, an Integrated Program of Products, Applications Guides, Optimization Tools, and Services</title>
            <link>http://www.pr.com/press-release/58278</link>
            <description>NCSRT Introduces WORKS&amp;trade;, an integrated program of products, applications guides, optimization tools, and services to dramatically improve downstream processing in the biopharmaceutical production environment. With the patented SmartFlow&amp;trade; TFF modules and industry leading PUROSEP&amp;reg; filtration skids at the core of the program, WORKS provides customers the ability to increase downstream yields and significantly [PR.com - October 30, 2007]</description>
            <author>NCSRT, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/58278</guid>
        </item>
    </channel>
</rss>
